Perennial second private to public fund fully subscribed

Perennial capital raising FE Analytics Andrew Smith Brendan Lyons Ryan Sohn

9 October 2020
| By Chris Dastoor |
image
image
expand image

Perennial’s Private to Public Opportunities fund No.2 fund (PPP2) has closed its capital raising fully subscribed, raising $125 million. 

The launch of the fund by Perennial followed the success of its first private companies fund (PPP), and the new strategy which announced in September, would employ the same investment strategy as its predecessor fund with the aim to generate superior returns over a five-year period. 

According to FE Analytics, the first Private to Public Opportunity  fund had returned 31.89% since inception on 16 August, 2019, to 31 August, 2020. 

The fund aimed to invest in high-growth equity opportunities through an actively managed portfolio of 30-45 unlisted, pre-IPO and listed Australian companies. 

Perennial said it had already identified several private and pre-IPO investments for the new fund, with the deployment of capital to commence immediately.  

Andrew Smith, Perennial head of smaller companies and microcaps, said: “We appreciate the support from investors for our initial PPP fund, as well as the strong demand experienced for PPP2. We are very pleased to reach the maximum fund target size of $125 million for our second PPP fund”. 

Brendan Lyons, Perennial head of private investments, said investors had been supportive of the fund’s investment strategy, which focused on the Last Private Offer (LPO) undertaken by founder-led companies prior to an IPO or other liquidity event. 

“Our systematic process, coupled with a large and growing pipeline of private opportunities, provides a diversified investment exposure which is otherwise difficult to access,” Lyons said. 

“In addition, increased volatility in global equity markets this year has prompted many investors to seek out alternate sources of return.” 

Ryan Sohn, deputy portfolio manager, said two of the initial investments included e-commerce businesses with significant scale as well as a health technology company with unique intellectual property.  

“We have followed the growth of these businesses for a significant period of time and are delighted to now be part of the journey with them,” Sohn said. 

Some of the businesses the first fund invested in included soft tissue regeneration business Aroa Biosurgery, diagnostic testing business Atomo Diagnostics and lung imaging technology firm 4D Medical, which all became listed on the Australian Securities Exchange (ASX) this year.  

Performance of the Perennial Private to Public Opportunity fund since inception to 31 August 2020 

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

1 month 3 weeks ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

2 months ago

Interesting. Would be good to know the details of the StrategyOne deal....

2 months ago

SuperRatings has shared the median estimated return for balanced superannuation funds for the calendar year 2024, finding the year achieved “strong and consistent positiv...

2 weeks 2 days ago

Original bidder Bain Capital, which saw its first offer rejected in December, has returned with a revised bid for Insignia Financial....

1 week 2 days ago

The FAAA has secured CSLR-related documents under the FOI process, after an extended four-month wait, which show little analysis was done on how the scheme’s cost would a...

1 week ago

TOP PERFORMING FUNDS